Gene · 7498
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-Activity Relationships and Changes in the Inhibition of Xanthine Oxidase by Polyphenols: A Review. | Foods | 2024 | 39123556 | PubTator, text mining | PubMed |
| Effects of Febuxostat Therapy on Circulating Adipokine Profiles in Patients with Overweight or Obesity and Asymptomatic Hyperuricemia: A Randomized Controlled Study. | Obes Facts | 2024 | 39116844 | PubTator, text mining | PubMed |
| Spock2 Functions as a Key Time-Series Gene of Endothelial Cells in Sepsis-Induced Cardiomyopathy. | J Cardiovasc Pharmacol | 2024 | 39115722 | PubTator, text mining | PubMed |
| An artificial metabzyme for tumour-cell-specific metabolic therapy. | Nat Nanotechnol | 2024 | 39103450 | PubTator, text mining | PubMed |
| Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes. | J Diabetes Investig | 2024 | 39078414 | PubTator, text mining | PubMed |
| Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy. | Pharmaceutics | 2024 | 39065635 | PubTator, text mining | PubMed |
| Efficacy and mechanism of the Ermiao San series of formulas for rheumatoid arthritis based on Chinmedomics strategy. | Phytomedicine | 2024 | 39047412 | PubTator, text mining | PubMed |
| The Cellular Genesis of Metabolic Syndrome and the Role of Anti-urate Drugs in Hyperuricemia Patients: A Systematic Review. | Cureus | 2024 | 39015868 | PubTator, text mining | PubMed |
| Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition. | Neurobiol Dis | 2024 | 39002811 | PubTator, text mining | PubMed |
| Inside the genome: understanding genetic influences on oxidative stress. | Front Genet | 2024 | 38983269 | PubTator, text mining | PubMed |
| Significance and amplification methods of the purine salvage pathway in human brain cells. | J Biol Chem | 2024 | 38960035 | PubTator, text mining | PubMed |
| Glutathione and Xanthine Metabolic Changes in Tamoxifen Resistant Breast Cancer Cell Lines are Mediated by Down-Regulation of GSS and XDH and Correlated to Poor Prognosis. | J Cancer | 2024 | 38947399 | PubTator, text mining | PubMed |
| Simiao pills alleviates renal injury associated with hyperuricemia: A multi-omics analysis. | J Ethnopharmacol | 2024 | 38936642 | PubTator, text mining | PubMed |
| The Antioxidant PAPLAL Protects against Allergic Contact Dermatitis in Experimental Models. | Antioxidants (Basel) | 2024 | 38929186 | PubTator, text mining | PubMed |
| Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease. | Antioxidants (Basel) | 2024 | 38929151 | PubTator, text mining | PubMed |
| What Makes a Mimic? Orange, Red, and Black Color Production in the Mimic Poison Frog (Ranitomeya imitator). | Genome Biol Evol | 2024 | 38874406 | PubTator, text mining | PubMed |
| Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients. | Glob Med Genet | 2024 | 38873557 | PubTator, text mining | PubMed |
| [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia]. | Yakugaku Zasshi | 2024 | 38825475 | PubTator, text mining | PubMed |
| Regulatory impacts of PPARGC1A gene expression on milk production and cellular metabolism in buffalo mammary epithelial cells. | Anim Biotechnol | 2024 | 38785376 | PubTator, text mining | PubMed |
| High nitrate levels in skeletal muscle contribute to nitric oxide generation via a nitrate/nitrite reductive pathway in mice that lack the nNOS enzyme. | Front Physiol | 2024 | 38784116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7498/papers?page=14